The 2018 winner of the GeekWire Awards‘ Geek of the Year will join the ranks of Northwest heavy hitters working to do good using technology. That includes last year’s pick,… Read More
Law and real estate expert Nelson Del Rio is taking on a new role at Seattle startup Blokable, one of last year’s Seattle 10 companies. Del Rio, who co-founded the startup… Read More
Luke Timmerman started climbing mountains with college buddies when he was in his 20s. He’s climbed Mount Rainier in Washington state (14,400 feet), Alaska’s Denali (20,000 feet) and even Argentina’s… Read More
Four decades ago, the overall chance of someone surviving cancer was about 50-50— not exactly a promising outlook. Today, those numbers have dramatically increased as new drugs and cancer-fighting biotechnologies… Read More
A study conducted by Fred Hutchinson Cancer Research Center, with contributions from researchers across North America, has found stark differences between children and adults with acute myeloid leukemia (AML), a… Read More
People with HIV or AIDS are at a much higher risk of developing and dying from cancer — in fact, cancer is now the leading cause of death for people with… Read More
For decades, bone marrow transplants have been a crucial treatment for blood cancers like leukemia and lymphoma — but scientists are still figuring out exactly how the transplants work. Scientists… Read More
Biotech journalist Luke Timmerman spends most of his time reading and writing about medical innovation. But now, he’s doing a lot more: Literally climbing Mount Everest to raise awareness, and… Read More
The president and director of Seattle’s Fred Hutchinson Cancer Research Center, Gary Gilliland, is bringing big-data experts on board to make good on his controversial prediction that there could be cures and… Read More
The Food and Drug Administration announced Wednesday that it has approved the first CAR T immunotherapy in the United States, a huge milestone for the group of breakthrough cancer treatments.… Read More
Cancer often seems to strike out of the blue, without warning or reason and often without a clear cause. But in some cases, the cause of a cancer is very… Read More
Seattle has long been a hub for innovative technology, and today the city is taking advantage of that technology more than ever with its Smart City program. To lead that… Read More
Boeing announced a structural reorganization this week to combine its safety, quality and manufacturing processes into one division, bringing several leadership changes along for the ride. Walt Odisho, formerly the company’s… Read More
Bryan Zug is a familiar face in the Seattle startup world. He’s an entrepreneur and product design expert himself, but he’s also an avid adviser and organizer of the startup… Read More
Do you ever feel like you’re addicted to apps? Or like they really get inside your head? Well, good news: You’re not imagining it. Introducing GeekWire’s new Health Tech podcast, exploring… Read More
Ovarian cancer is a tricky disease to treat. About 20 percent of those diagnosed don’t respond to the standard treatment, which means they lose precious time taking a treatment that… Read More
Immunotherapy — treatments that harness the body’s immune system to fight cancer — have seen promising results in blood cancers like leukemia and lymphoma. But those same treatments have proven difficult… Read More
When new car owners are picking license plates in Washington state, they can choose to pay a bit extra for a specialty plate from organizations like the University of Washington or… Read More
Dr. Matthias Stephan has a vision: cancer-killing immunotherapy that is so cheap and easy to access it replaces chemotherapy as the front-line treatment for cancer. “What I envision is like the… Read More
If the immune system is an army, then T-cells are soldiers on the front lines, attacking invading viruses and other agents of disease. But not every soldier is the same; some… Read More
Immunotherapy — using the body’s immune system to fight disease — has already made great strides in cancer treatment, with the Seattle region emerging as an epicenter for the approach. But could… Read More
For cancer researchers, understanding the intricacies of a cell is essential to treating patients and developing new therapies. Often this understanding is found through painstaking examination of a cell’s surface… Read More
Fred Hutchinson Cancer Research Center, which has spun-out companies such as Juno Therapeutics and Nohla Therapeutics in recent years, is continuing its aggressive push to commercialize more of its research. The… Read More
Immunotherapy is simple in theory, but endlessly complex in practice. This type of treatment uses the body’s immune system — a system designed to find and attack microscopic invaders —… Read More
Merkel Cell Carcinoma (MCC) is a nasty disease. This rare skin cancer is treatable, but as Dr. Paul Nghiem explains, treating the initial disease is only the first step. “Even though you treat… Read More
For decades, bone marrow transplants have been an integral treatment for patients with Leukemia and other blood diseases. And now, researchers at Fred Hutchinson Cancer Research Center may be able… Read More
There are two basic models for scientific research — industry and academia — and each has its strengths. Academia can support sustained, long-term research. Industry is better at pushing the envelope with its entrepreneurial… Read More
Scientists at Seattle’s Fred Hutchinson Cancer Research Center have figured out how to use venom from the Israeli deathstalker scorpion to “light up” cancerous cells, making it easier for surgeons to distinguish them… Read More
To many, immunotherapies — treatments that use a patient’s immune system to fight cancer— sound like something from an episode of Star Trek. In CAR T cell therapy, for example, a… Read More
— DreamBox Learning, the Bellevue, Wash.-based digital education company, has added Jennifer Agustin, a former LinkedIn marketing executive, as its new vice president of marketing. Agustin’s role will be to… Read More